Aromatic L-Amino Acid Decarboxylase Neurons <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">AADC Neurons</th>
</tr>
<tr>
<td class="label">
Category </td>
<td>Neuromodulatory</td>
</tr>
<tr>
<td class="label">
Location </td>
<td>CNS, peripheral</td>
</tr>
<tr>
<td class="label">
Enzyme </td>
<td>Aromatic L-amino acid decarboxylase</td>
</tr>
<tr>
<td class="label">
Function </td>
<td>Catecholamine synthesis</td>
</tr>
<tr>
<td class="label">Gene/Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">
AADC (DDC) </td>
<td>Dopamine synthesis enzyme</td>
</tr>
<tr>
<td class="label">
[TH](/genes/th) </td>
<td>Rate-limiting step</td>
</tr>
<tr>
<td class="label">
[VMAT2](/proteins/vmat2-protein) </td>
<td>Neurotransmitter packaging</td>
</tr>
<tr>
<td class="label">
[DAT](/proteins/dat-protein) </td>
<td>Dopamine reuptake</td>
</tr>
<tr>
<td class="label">
[COMT](/proteins/comt-protein) </td>
<td>Dopamine metabolism</td>
</tr>
<tr>
<td class="label">
[BDNF](/proteins/bdnf-protein) </td>
<td>Neuronal survival</td>
</tr>
<tr>
<td class="label">
[LRRK2](/genes/lrrk2) </td>
<td>Kinase dysfunction</td>
</tr>
</table>
Introduction Aadc Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...
Aromatic L-Amino Acid Decarboxylase Neurons <table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">AADC Neurons</th>
</tr>
<tr>
<td class="label">
Category </td>
<td>Neuromodulatory</td>
</tr>
<tr>
<td class="label">
Location </td>
<td>CNS, peripheral</td>
</tr>
<tr>
<td class="label">
Enzyme </td>
<td>Aromatic L-amino acid decarboxylase</td>
</tr>
<tr>
<td class="label">
Function </td>
<td>Catecholamine synthesis</td>
</tr>
<tr>
<td class="label">Gene/Protein</td>
<td>Function</td>
</tr>
<tr>
<td class="label">
AADC (DDC) </td>
<td>Dopamine synthesis enzyme</td>
</tr>
<tr>
<td class="label">
[TH](/genes/th) </td>
<td>Rate-limiting step</td>
</tr>
<tr>
<td class="label">
[VMAT2](/proteins/vmat2-protein) </td>
<td>Neurotransmitter packaging</td>
</tr>
<tr>
<td class="label">
[DAT](/proteins/dat-protein) </td>
<td>Dopamine reuptake</td>
</tr>
<tr>
<td class="label">
[COMT](/proteins/comt-protein) </td>
<td>Dopamine metabolism</td>
</tr>
<tr>
<td class="label">
[BDNF](/proteins/bdnf-protein) </td>
<td>Neuronal survival</td>
</tr>
<tr>
<td class="label">
[LRRK2](/genes/lrrk2) </td>
<td>Kinase dysfunction</td>
</tr>
</table>
Introduction Aadc Neurons is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
AADC is the enzyme that converts L-DOPA to dopamine. [@kuhl2020]
Overview
AADC Function
DOPA decarboxylation : Final step to dopamine5-HTP decarboxylation : Serotonin synthesisVitamin B6 dependent : Cofactor requirementAADC deficiency : Genetic neurotransmitter disorderRole in Neurodegeneration
[Parkinson's Disease](/diseases/parkinsons-disease)
AADC activity : Marker of remaining [dopaminergic neurons](/cell-types/dopaminergic-neurons)Fluctuations : AADC capacity limits [levodopa](/therapeutics/levodopa) responseGene therapy : AADC delivery via [AAV vectors](/technologies/aav-vectors)[Fluorodopa PET](/diagnostics/fluorodopa-pet) : Imaging marker for [substantia nigra](/cell-types/substantia-nigra) integrityAADC Gene Therapy
AAV vectors : Putamen injectionClinical trials : Gene therapyComBINE trial : AADC optimizationMolecular Mechanisms AADC neurons operate through several key molecular mechanisms:
Catecholamine Synthesis
[Dopamine biosynthesis](/mechanisms/dopamine-biosynthesis) : AADC catalyzes the decarboxylation of L-DOPA to dopamine[Serotonin synthesis](/mechanisms/serotonin-pathway) : AADC also converts 5-HTP to serotoninVitamin B6 dependence : Pyridoxal phosphate is an essential cofactorNeurotransmitter Regulation
Tyrosine hydroxylase : Rate-limiting step before AADCVMAT2 : Vesicular packaging of synthesized neurotransmittersDAT : Dopamine reuptake regulationBasal ganglia circuitry : AADC activity in PDNeuroinflammation : Effects on AADC functionOxidative stress : Impact on enzyme activityKey Genes and Proteins
Signaling Pathways
cAMP/PKA signaling : Dopamine receptor signalingPI3K/Akt pathway : Cell survival signalingMAPK/ERK pathway) : Growth factor signalingCalcium signaling : Excitotoxicity mechanismsTherapeutic Implications
Disease-Modifying Approaches
AADC gene therapy : [AAV-mediated](/technologies/aav-vectors) AADC delivery to [striatum](/cell-types/striatal-medium-spiny-neurons)Cell replacement : [AADC-expressing stem cell transplants](/cell-types/ipsc-derived-dopaminergic-neurons)Enzyme enhancement : Small molecule AADC activatorsNeuroprotective Strategies
[GDNF](/proteins/gdnf-protein) : Neuronal survival factors[BDNF analogs](/proteins/bdnf-protein) : Support AADC neuron functionAntioxidants : Protect AADC activity from [oxidative stress](/mechanisms/oxidative-stress)Symptomatic Treatments
[Levodopa](/therapeutics/levodopa) : AADC substrate for dopamine synthesis[MAO-B inhibitors](/therapeutics/mao-b-inhibitors) : Prevent dopamine breakdown[Dopamine agonists](/therapeutics/dopamine-agonists) : Bypass AADC limitationEmerging Therapies
Optogenetics : Light-based modulation of AADC neuronsChemogenetics : Designer receptors for neuronal controlGene editing : CRISPR-based AADC enhancementDisease Associations
[Parkinson's disease](/diseases/parkinsons-disease) : Primary AADC neuron disorder[Multiple system atrophy](/diseases/multiple-system-atrophy) : Atypical parkinsonism affecting AADC[Progressive supranuclear palsy](/diseases/progressive-supranuclear-palsy) : Tauopathy with parkinsonian features[AADC deficiency](/diseases/aadc-deficiency) : Genetic neurotransmitter disorder[Dopa-responsive dystonia](/diseases/dopa-responsive-dystonia) : AADC-related movement disorderBackground The study of Aadc Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[Parkinson's disease](/diseases/parkinsons-disease) alpha-synuclein
genetic factors
APOE4
biomarkers
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
Show full description